Upgrade to SI Premium - Free Trial

Apellis Pharmaceuticals (APLS)

41.03 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/31/26 *Est.)

Latest Headlines

Needham Reiterates Buy Rating on Apellis Pharmaceuticals (APLS) July 28, 2026 7:16 AM - StreetInsider Full Article List